Israel - English - Ministry of Health

teva israel ltd - benzylpenicillin sodium - powder for solution for injection - benzylpenicillin sodium 5 miu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin sensitive organisms.

Israel - English - Ministry of Health

teva israel ltd - benzylpenicillin sodium - powder for solution for injection - benzylpenicillin sodium 10 mu/vial - benzylpenicillin - benzylpenicillin - infections due to penicillin - sensitive microorganisms.

Ireland - English - HPRA (Health Products Regulatory Authority)

ovelle limited - benzyl benzoate - cutaneous emulsion - 25 percent weight/volume - other ectoparasiticides, incl. scabicides; benzyl benzoate

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - benzylpenicillin potassium - powder for solution for infusion or injection - benzylpenicillin potassium 625 mg - antibacterials for systemic use

Malta - English - Medicines Authority

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - benzylpenicillin potassium - powder for solution for infusion or injection - benzylpenicillin potassium 1250 mg - antibacterials for systemic use

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - benzylpenicillin - powder for solution for injection/infusion - 3000 milligram(s) - benzylpenicillin

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - benzylpenicillin - powder for solution for injection/infusion - 600 milligram(s) - benzylpenicillin

United States - English - NLM (National Library of Medicine)

dash pharmaceuticals llc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. diclofenac sodium and misoprostol delayed-release tablets should not be taken by pregnant women. diclofenac sodium and misoprostol delayed-releas

Canada - English - Health Canada

jamp pharma corporation - valproic acid (sodium valproate) - solution - 250mg - valproic acid (sodium valproate) 250mg

Kenya - English - Pharmacy and Poisons Board

laboratory & allied ltd p.o box 42875 gpo 00100 nairobi kenya - benzyl penicillin - powder for solution for injection - benzylpenicillin as sodium salt bp (1mega) - beta-lactamantibacterials: penicillins